Svelte Medical Systems, Inc. Completes 6 month Follow-up With Its “All In One” Stenting System

NEW PROVIDENCE, N.J.--(BUSINESS WIRE)--Svelte™ Medical Systems, Inc. is pleased to announce that it has completed 6 month follow up in its initial clinical trial with the Svelte Acrobat angioplasty system. The Svelte Acrobat is a low profile “All in One” stenting system with balloon control technology designed to reduce time and cost and improve safety in an angioplasty procedure. “This is truly a significant milestone for the Company. We are very pleased to see the excellent clinical results” said Mark Pomeranz, President and CEO of Svelte Medical Systems, Inc.